BACKGROUND: Mitochondria are the powerhouse of mammalian cells and the
consumption. In addition, they also play a strategic role in controlling the fate of cells through regulation of death pathways. Mitochondrial ROS production fulfills a signaling role through regulation of redox pathways, but also contributes to mitochondrial damage in a number of pathological states. SCOPE OF REVIEW: Mitochondria are exposed to the constant generation of oxidant species, and yet the organelle remains functional due to the existence of an armamentarium of antioxidant defense systems aimed to repair oxidative damage, of which mitochondrial glutathione (mGSH) is of particular relevance. Thus, the aim of the review is to cover the regulation of mGSH and its role in disease. MAJOR CONCLUSIONS: Cumulating evidence over recent years has demonstrated the essential role for mGSH in mitochondrial physiology and disease. Despite its high concentration in the mitochondrial matrix, mitochondria lack the enzymes to synthesize GSH de novo, so that mGSH originates from cytosolic GSH via transport through specific mitochondrial carriers, which exhibit sensitivity to membrane dynamics. Depletion of mGSH sensitizes cells to stimuli leading to oxidative stress such as TNF, hypoxia or amyloid β-peptide, thereby contributing to disease pathogenesis. GENERAL SIGNIFICANCE:
Understanding the regulation of mGSH may provide novel insights to disease pathogenesis and toxicity and the opportunity to design therapeutic targets of intervention in cell death susceptibility and disease.
INTRODUCTION
Despite its exclusive synthesis in the cytosol, GSH is distributed in intracellular organelles, including endoplasmic reticulum (ER), nucleus and mitochondria.
The compartmentalization of GSH in separate redox pools is critical to control compartment-specific needs and functions [1, 2] . In the nucleus, GSH maintains critical protein sulphydryls that are necessary for DNA repair and expression [3] and functions also as a hydrogen donor in ribonucleotide reductase-catalysed reduction of ribonucleotides to deoxyribonucleotides, thus playing a contributory role in DNA synthesis [4] . Intracellularly GSH is predominantly found in its reduced form except in the ER, where it exists mainly as oxidized glutathione (GSSG), GSSG being the main source of oxidizing equivalents to provide the adequate environment necessary for disulphide bond formation and proper folding of nascent proteins [5] . In mitochondria, however, GSH is mainly found in reduced form and represents a minor fraction of the total GSH pool (10-15%). Considering the volume of the mitochondrial matrix, the concentration of mitochondrial GSH (mGSH) is similar to that of cytosol (10-14 mM) [1, 2, 6, 7] .
Mitochondria are an excellent example of subcellular organelles whose function is closely linked to maintenance of redox balance. The mitochondria are the primary intracellular site of oxygen consumption and the major source of reactive oxygen species (ROS), most of them originating from the mitochondrial respiratory chain. Associated with this constant flow of ROS generation mitochondria are a target for the damaging effects of oxygen radicals [8] [9] [10] .
Although normal electron transport in mitochondria involves four-electron reduction of molecular oxygen to water, partial reduction reactions occur even under physiological conditions, causing release of superoxide anion (O· 2-) and hydrogen peroxide. In accordance with this, it has been estimated that the steady-state concentration of O· 2- in the mitochondrial matrix is five-to tenfold higher than in the cytosol [11] .
In addition to the ROS generated under physiological settings, toxic or pathological conditions that lead to an impairment of mitochondrial function can increase the release of ROS. Therefore, although mitochondria are exposed to the constant generation of oxidant species, the organelle remains functional due to the existence of an antioxidant defense system, of which mGSH is a critical component, aimed to prevent or repair oxidative damage generated during normal aerobic metabolism. This review summarizes current knowledge on the physiology and function of mGSH and its role in cell death regulation and pathological states.
Mitochondrial Oxidative Stress and defense
The primary function of mitochondria is to transduce oxygen consumption in the electron transport chain (ETC) into energy required for myriad cell functions.
Although the process is highly efficient, a small fraction of electrons are transferred directly to molecular oxygen, resulting in the generation of O 2 · -, which can give rise to other potent ROS as well as reactive nitrogen species (RNS). Therefore, a fine equilibrium between ROS production and removal will determine the physiological vs. pathological function of ROS. Mitochondria contain an arsenal of antioxidant systems with target specificity [1] .
Superoxide dismutase
The first line of defense against ROS is guaranteed by the presence of Mn Shc is a cytoplasmic protein involved in signaling from tyrosine kinases to Ras, which translocates to mitochondria in response to stress contributing to cell death and aging. It has been shown that p66 Shc directly stimulates hydrogen peroxide generation, without inhibiting mitochondrial respiration, by transferring electrons to cytochrome c [12] .
Glutathione Redox Cycle
Although hydrogen peroxide is not a free radical, it is an oxidant and an intermediate in the chain of reactions that generate reactive free radicals, such as hydroxyl radical, which can oxidize mitochondrial components (proteins, lipids, DNA). Since most mitochondria lack catalase, perhaps with the demonstrated exception of rat heart mitochondria [13] , the metabolism of hydrogen peroxide is mainly accomplished by GSH, with the participation of either GSH peroxidase or peroxiredoxins. Associated with this function GSH becomes oxidized to GSSG, which is reduced back to GSH by the NADPHdependent GSSG reductase (GR), as shown in Figure 1 . Among GSH peroxidases (Gpx) that detoxify hydrogen peroxide, Gpx1 is the major isoform localized mainly in the cytosol, with a small fraction also present in the mitochondrial matrix [2, 14] . Some potent electrophiles, especially those generated as a consequence of metabolic processes involving both endogenous compounds and xenobiotics, can be readily removed by GSH via catalysis by glutathione transferases (GSTs). GSTs are distributed in mitochondria (GSTA1), cytosol (alpha, mu, pi, and zeta) and membrane-bound (MGST1) isoforms [15, 16] . Mitochondrial GSTs display both glutathione transferase and peroxidase activities that detoxify harmful byproducts through GSH conjugation or GSH-mediated peroxide reduction [15, 17] . Among human mitochondrial GSTs, the isoforms hGSTA4-4, hGSTA1, hGSTA2, and hGSTP1
showed peroxidase activity, with hGSTA4-4 exhibiting the highest activity [18, 19] .
mGSH is also the primary defense against oxidative damage to mitochondrial membranes by insuring the reduction of hydroperoxides present on phospholipids and other lipid peroxides. These modified lipids are detoxified by mGSH through the actions of mitochondrial GSTs with modest Se-independent Gpx activity, as well as specific GSH peroxidases, such as Gpx4 which displays high preference for lipid hydroperoxides (Figure 1 ). Actually, due to its capacity to reduce hydroperoxide groups on phospholipids, cholesteryl esters and lipoproteins, Gpx4 is considered a critical defense enzyme in protecting membranes against oxidative stress. Gpx4 is synthesized in three forms that arise from the same Gpx4 gene displaying different translation initiation sites. A short form of Gpx4 is present in somatic tissue mitochondria and is essential for survival and protection against apoptosis in mice, whereas a long form has been shown to be important for male fertility [20] [21] [22] 
Thioredoxins
Regarding the thioredoxin (Trx) system in mammals, both Trx and TrxR are expressed as isoforms for both predominantly cytosolic (Trx1 and TrxR1) or mitochondrial (Trx2 and TrxR2) localization [34] . There are direct links between the Trx system and protein glutathionylation [35] ; and the direct reduction of mitochondrial Grx2 by TrxR is also of important physiological relevance [33, 34] .
However, the reduction of the intermolecular disulfide is specific to Trx and can not be achieved by GSH or glutaredoxin. Mitochondria-specific Trx and TrxR, can interact also with the peroxiredoxins (Prxs), which constitute a novel family of thiol-specific peroxidases that rely on Trx as the hydrogen donor for the reduction of hydrogen peroxides and lipid-hydroperoxides [36] .
Peroxiredoxins
One Prx isoform, Prx3, is exclusively detected in mitochondria, suggesting that shown that Prx5 can be targeted to mitochondria, peroxisomes, the cytosol, and the nucleus. The targeting of Prx5 to mitochondria is highly conserved among species [39] , and it has been associated with the protection of mtDNA from oxidative attacks [40] . Prx5 is a peroxidase that can use cytosolic or mitochondrial thioredoxins to reduce alkyl hydroperoxides or peroxynitrite with high rate constants, whereas its reaction with hydrogen peroxide is modest [38] .
So far, Prx5 has been viewed mainly as a cytoprotective antioxidant enzyme rather than as a redox sensor. Thus, more than 10 years after its molecular cloning, mammalian Prx5 appears to be a unique peroxiredoxin exhibiting specific functional and structural features [38, 41] .
An interesting issue centers on the relative importance of the mitochondrial GSH redox (mGSH/Gpx) vs PrxIII/Trx2 system on hydrogen peroxide defense.
The relevance of GSH peroxidases, in particular the mitochondrial targeted Gpx4, in oxidative stress defense and hydrogen peroxide elimination is illustrated by the fact that Gpx4 knockout mice is embryonic lethal [26] .
However, recent studies identified PrxIII as an essential line of defense against mitochondrial hydrogen peroxide [37] , with the estimation by kinetic competition analysis that a large amount of hydrogen peroxide generated in mitochondria targets PrxIII [42] . In addition, selective depletion of mGSH has been shown to sensitize hepatocytes to oxidant cell death [2, 6, 8] [37] , while reporting the role of mGSH in oxidant cell death have been typically done in primary hepatocytes [2, 6, 8] . Although further specific work addressing these features is needed, current evidence has shown that both antioxidant systems (mGSH and PrxIII) are clearly interconnected. For instance, it has been described that depletion of mGSH results in Trx2 oxidation [43] . Similarly, in a recent study using hypercholesterolemic pigs they observed a selective depletion of mGSH in heart mitochondria, with the spare of cytosol GSH that was followed by profound decreases in the levels of the mitochondriaspecific antioxidant enzymes such as MnSOD, Trx2, and PrxIII [44] . However, the influence of PrxIII on the GSH redox cycle status has not been addressed.
Together, these data provide evidence for an essential role of the mitochondrial GSH redox cycle in maintaining a healthy antioxidant system, and consequently, on hydrogen peroxide homeostasis.
NADPH sources
Since the regeneration of GSSG or oxidized Trx is dependent on reducing 
mGSH Transport
Despite the high GSH concentration existing in mitochondrial matrix, GSH is not synthesized de novo as mitochondria lack the enzymes required for the synthesis of GSH from its constituent aminoacids. Therefore, mitochondrial GSH arises from the cytosol GSH by the activity of specific carriers [7] .
Furthermore, GSH has an overall negative charge at physiological pH and mitochondria exhibit a large negative membrane potential; consequently, although GSH can cross easily the mitochondrial outer membrane (MOM) through porin channels its transport into mitochondrial matrix cannot be explained by simple diffusion. Indeed, recent findings using dynamic oxidant recovery assays together with GSH-specific fluorescent reporters, determined the free communication of GSH pools between cytosol and the intermitochondrial space (IMS). In contrast, no appreciable communication was observed between the GSH pools of the IMS and matrix [53] .
mGSH transport in kidney
Previously, two mitochondrial inner membrane (MIM) anion carriers were identified in kidney and liver as GSH transporters, the 2-oxoglutarate carrier (OGC; Slc25a11) and the dicarboxylate carrier (DIC; Slc25a10) [54-57]. These antiport carriers, OGC and DIC, import cytosolic GSH into mitochondria in exchange for 2-oxoglutarate (2-OG) and inorganic phosphate (Pi
respectively [2] . In reference to the presence of mGSH carriers in kidney, Lash et al. [58] showed that overexpression of the rat kidney DIC carrier in a cell line derived from rat kidney proximal tubules (NRK-52E) increased the mGSH pool . These findings suggest that the OGC accounts for the low-affinity high capacity of GSH transport in liver mitochondria, and imply that the nature of the high affinity GSH transporter remains to be identified. However, whether these carriers also participate in the efflux of mGSH in exchange for cytosolic GSH is unknown. In line with this, intriguing findings indicated that inhibition of OGC or DIC by phenylsuccinate or butylmalonate in kidney HRK523 cells resulted in increased rather than decreased mGSH levels, suggesting the possibility for OGC/DIC to mediate GSH efflux from mitochondria [60] . Moreover, as opposed to release of GSSG from cells, recent studies argue that GSSG does not efflux out of mitochondria, implying that under oxidant conditions, the accumulation of GSSG contributes to mitochondrial protein glutathionylation and subsequent impaired function [61] . In addition, since regeneration of GSH in mitochondria is dependent on reduced environment and NADPH availability, mGSH is highly dependent on the respiratory substrates used to produce NADPH [61] , and on the availability of the reduced nucleotide cofactor.
mGSH transport in brain
However little is known about mGSH transport in organs different from liver and kidney. In brain, some studies have examined the mechanisms responsible for mitochondrial GSH transport. In one report, the properties of GSH transport in isolated rat brain mitochondria seemed to be greatly different from those reported previously for mitochondria from kidney, and influenced most by inhibitors of the tricarboxylate carrier rather than OGC or DIC [62] . However, in mouse brain mitochondria another study showed that OGC and DIC are both expressed in cortical neurons and astrocytes [63] . In addition, butylmalonate, an inhibitor of DIC, significantly decreased mGSH, suggesting DIC as the major GSH transporter in mouse cerebral cortical mitochondria [63] . Moreover, a role for UCP2 in the transport of mitochondrial GSH has been described in neurons,
suggesting that the transport of protons back into the matrix by UCP2 may favor the movement of GSH [64] . These studies suggest that, in the brain, multiple MIM anion transporters might be involved in mGSH transport, however, essentially nothing is known about how the function of these carriers is
regulated. An interesting recent study, suggested the participation of Bcl-2 as a binding partner for mGSH, consequently enhancing its affinity for the OGC [46] .
In this context, the binding of recombinant Bcl-2 to GSH in vitro, was antagonized by the Bcl-2 homology-3 domain (BH3) mimetics HA14-1 and compound 6, as well as the BH3-only protein, Bim [65] . Bcl-2 and OGC appear to act in a coordinated manner to increase the mGSH pool and to enhance the resistance of neurons to mitochondrial oxidative stress. Therefore, the antioxidant-like function attributed to Bcl-2 could in part depend on its potential to regulate the cellular glutathione status [57].
Unlike 2-OG and DIC carriers, the evidence for these alternative carriers and regulators in the transport of mGSH in hepatic liver mitochondria remains to be established. A key feature of the transport of GSH through OGC is its strict dependence on appropriate membrane dynamics, which is determined by fatty acid composition and the cholesterol/phospholipid molar ratio [56, 66] .
Cholesterol is a critical component of membranes with key structural and functional roles [67] . Compared to plasma membrane, mitochondria are much less enriched in cholesterol with estimates of about 3-5% of the total cholesterol cell load [68] . This restricted pool of cholesterol in mitochondria, however, plays a fundamental physiological role in the synthesis of bile acids in hepatocytes or steroidogenic hormones in specialized tissues [69] . Given the role of cholesterol in the regulation of membrane dynamics and physical properties, the synthesis and supply of membrane cholesterol is highly regulated under physiological conditions. Cholesterol is known to regulate membrane organization [55] . In this regard, it has been shown that cholesterol loading in mitochondria results in increased membrane order parameter which negatively impacts specific membrane carriers, such as the GSH transport system without effect in others, including the S-adenosyl-L-methionine transport system [70] . Functional expression studies in Xenopus laevis oocytes provided clear evidence that the OGC is highly sensitive to mitochondrial membrane fluidity loss induced by cholesterol loading [56] . Thus, one of the functional consequences of mitochondrial cholesterol enrichment is the impairment of mGSH transport which results in depletion of GSH in the mitochondrial matrix.
This selective pool of GSH has been shown to play a key role in controlling cell susceptibility to oxidative stress, Ca 2+ overload, TNF/Fas, and hypoxia [71] [72] [73] [74] [75] [76] , and its depletion has been shown to contribute to a number of pathologies, some of which will be covered below [2, 8, [77] [78] [79] [80] .
mGSH and Cell Death.
Mitochondria play a central role in various forms of cell death, which are characterized by differential biochemical features, with predominant forms including apoptosis (caspase-dependent and independent), or necrosis. Once cytochrome c is released it binds to monomeric Apaf-1 which then, in a dATP-dependent conformational change, oligomerizes to assemble the apoptosome, a complex that triggers the activation of the initiator procaspase-9.
Activated caspase-9 subsequently initiates a caspase cascade involving downstream effector caspases, such as caspase-3, ultimately resulting in the execution of apoptosis [90] . insures caspase-independent mitochondria-mediated apoptosis inducing chromatin condensation and DNA fragmentation [91] .
As opposed to apoptosis, necrosis is a morphologically distinct form of cell death responsible for irreversible tissue destruction due to bioenergetic failure and oxidative damage. The fundamental difference to apoptosis is the rapid loss of cellular membrane potentials due to energy depletion and ion pump/channel failures, leading to swelling, rupture and cytolysis. Rather than being a passive event, necrosis has emerged as a controlled cell death that induces an inflammatory response to stimulate tissue repair by releasing specific factors from dying cells such as HMGB1 and HDGF [92] . Necrosis is dependent on the mitochondrial permeability transition pore (mPT), a channel complex that spans outer and inner mitochondrial membranes at points of contact [93] . mPT is a regulated nonselective water and soluble-passing protein complex whose molecular identity is still debated. It can encompass voltage-dependent anion channel (VDAC) across the MOM and adenine nucleotide translocase (ANT) across the MIM [91, 94] . In contrast to VDAC and ANT, the prolyl isomerase cyclophilin D in the mitochondrial matrix is an essential regulator of mPT and the only genetically proven indispensable mPT component [95] [96] [97] [98] . Upon oxidative stress, sudden mPT causes massive ion influx that dissipates mitochondrial membrane potential and shuts down oxidative phosphorylation, ATP production, and ROS overgeneration. Concomitantly, water influx causes matrix swelling, rupture of the rigid MOM and release of apoptogenic proteins sequestered in IMS. Although cytochrome c is released, apoptotic cell death under mPT is inhibited due to energetic failure and ATP exhaustion and oxidative stress-mediated caspase inactivation. Thus, although mitochondria are is the strategic center in the control of cell death, the outcome of MOMP leading to apoptosis or necrosis is determined by the nature and intensity of stimuli and whether mPT is engage [99] . Thus, the mPT induces cell death, and depending on the level of cellular ATP, as ATP is required for the efficient assembly of the apoptosome and/or the extent of ROS generation, apoptosis and/or necrosis will ensue [83, 91, [100] [101] [102] . Consequently, understanding the mechanisms leading to MOMP is essential for designing strategies to control cell death.
In this regard, although the field has mainly focused on the role of Bcl-2 family . In addition, it has been described that oxidized cardiolipin modulates the biophysical properties of MOMP to allow oligomerized Bax to insert and permeabilize the mitochondrial outer membrane [68, 76, 108] . Altogether, these results support the hypothesis that cardiolipin is a key upstream target in mitochondria-dependent apoptosis. Despite only a small fraction of cytochrome c being bound to cardiolipin (about 15%), the oxidation of this lipid is thought to impact the mobilization of cytochrome c from the mitochondria, although the relevance of this step in the release of cytochrome c to the cytosol is controversial. Since mitochondrial ROS contribute to cardiolipin oxidation and are controlled by antioxidants such as GSH [2, 76] , mGSH arises as an important modulator of apoptotic cell death by indirectly controlling the redox state of cardiolipin [68, 76] . Accordingly, mGSH depletion due to alcoholmediated alteration in mitochondrial membrane dynamics underlies the susceptibility of hepatocytes from alcohol-fed models to tumor necrosis factor (TNF) [109] , and in nutritional and genetic models of hepatic steatosis [75, 110] , mGSH depletion occurs due to the enrichment of mitochondria in free cholesterol, resulting in decreased mitochondrial membrane fluidity [75] . Of importance, this effect was reproduced after selectively depleting mGSH in "healthy" hepatocytes by means of using 3-hydroxy-4-pentenoate (HP) which undergoes mitochondrial biotransformation into a Michael electrophile followed by its conjugation with GSH in the mitochondrial matrix [111] , thereby sensitizing them to the inflammatory cytokine TNF [6, 76, 112, 113] . Moreover, the susceptibility to TNF after mGSH depletion, and subsequent cardiolipin oxidation was observed despite unimpaired GPx, Trx2, and Prx3, thus highlighting the relevance of mGSH in cell protection under oxidative stress [76] . In addition, similar sensitization by mGSH depletion was observed in neurons and glia cell lines challenged with amyloid-beta mediated cell death [80] . In addition, in cerebellar granule neurons, while direct depletion of mitochondrial and cytoplasmic GSH resulted in increased generation of ROS, decrease of the mPT, rapid loss of mitochondrial function, and cell death without apoptotic features, these effects were not observed if mGSH was relatively maintained [114] . Additionally, in astrocytes, a selective loss of mGSH, as a result of treatment with ethacrynic acid, increased cell vulnerability to peroxynitrite and hydrogen peroxide whereas protection was afforded by prior elevation of the mGSH pool by GSH ethyl ester, thus providing new direct evidence for the importance of mGSH in protection against necrotic cell death induced by reactive oxygen and nitrogen species [115] . Overall, these studies in consumption, whereas the cytotoxic effects appear to be mediated by a rapid and selective depletion of mGSH that accompanied the increased generation of ROS and mitochondrial dysfunction. Interestingly, the toxic effects of CDDO-Me were followed by rapid autophagocytosis of intracellular organelles or the externalization of phosphatidylserine in different cell types [116, 117] , indicating that alterations in mitochondrial function by CDDO-Me can result in autophagy or apoptosis of chronic myeloid leukemia. These observations have also been extended to ovarian cancer cells [118] . Similarly, β-phenethyl isothiocyanate (PEITC), a natural product with potent anticancer activity against human leukemia cells, caused a rapid depletion of mitochondrial GSH and a significant elevation of ROS and nitric oxide, induced a disruption of the mitochondrial electron transport complex I, and a significant suppression of mitochondrial respiration that resulted in cytotoxicity in leukemia cells [119] . Taken collectively, these findings provide a basis for developing new therapeutic strategies to effectively cancer cells by using drugs that selectively deplete mGSH stores.
mGSH in pathology
Examples for the contribution of mGSH to different diseases have increased over the years. In many pathological settings mGSH depletion is both the consequence of disease progression and the cause of organ failure, and in most cases related to cholesterol-mediated changes in membrane dynamics.
Indeed, mitochondrial cholesterol has emerged as an important modulator of MOMP in response to apoptotic stimuli underlying the importance of this lipid in disease pathogenesis, including alcoholic and nonalcoholic steatohepatitis, Alzheimer's disease or hepatocellular carcinoma [68, 69, 75, 120] by regulating mGSH transport, mGSH homeostasis and subsequent protection of cardiolipin from peroxidation (Figure 3) .
In the following sections we will briefly cover the best characterized examples of the role of mGSH depletion in disease pathogenesis.
Neurological disorders
The brain is particularly vulnerable to oxidative damage because of its high oxygen utilization, content of oxidizable polyunsaturated fatty acids, and presence of redox-active metals (Cu, Fe). Oxidative stress increases with age and therefore it can be considered as an important causative factor in several [124, 125] . Not only Aβ may cause mitochondrial ROS production, but also it is becoming clear that oxidative damage occurs early in the AD brain, even before the onset of significant plaque pathology [126] . Recent findings tested the hypothesis that mitochondrial cholesterol modulated Aβ neurotoxicity and AD pathology [68] . Using genetic models of cholesterol loading, it was found that and semiquinone species and ROS [127, 128] . According to postmortem studies, GSH levels in the SNpc of PD patients are remarkably lower than those of healthy subjects (60% compared to control subjects) while oxidized glutathione (GSSG) levels are slightly increased. GSH loss in PD is also accompanied by a reduction in mitochondrial complex I activity, which is regionally selective for the substantia nigra in PD and does not occur in related basal ganglia degenerative disorders. Consistent with these findings, we have shown that selective mGSH depletion mice sensitized to in vivo injection of 3-nitropropionic acid (3-NP), a mitochondrial toxin used extensively as a model of HD [129] . 3-NP delivery into the striatum of caveolin-1 knockout mice resulted in extensive areas of degeneration and cell death compared to wild type mice.
Moreover, following occlusion of the middle cerebral artery in rat brain, early and selective loss of mGSH has been reported [130] . The mGSH depletion
showed an apparent association with the tissue damage that developed during subsequent reperfusion, suggesting that it could be an important determinant of susceptibility to cell loss. In fact, brain infusion of GSH-monoethyl ester (GSH-EE) increased cellular GSH and was particularly effective in replenishing the mitochondrial pool, and reduced infarct size from 46% of the total ischaemic hemisphere in saline-treated animals to 16% following GSH-EE treatment, thus providing neuroprotection following transient focal cerebral ischaemia [131] .
Thus, these findings illustrate the relevance in searching for optimal means to deliver GSH precursors and prodrugs to the central nervous system as a strategy for neurodegeneration [132] . However, an additional challenge in this aim is to satisfactorily reach mitochondria to increase the mGSH pool despite impaired transport due to loss of membrane physical properties.
Liver diseases
The implication of oxidative stress in liver diseases has been well characterized, playing a role in diseases such as viral hepatitis, metabolic liver diseases, ischemia/reperfusion injury and drug toxicity. Steatohepatitis, however, is one of the best characterized examples where mGSH depletion plays an important role in disease pathogenesis. Steatohepatitis represents an advanced stage in the spectrum of fatty liver disease that encompasses alcoholic (ASH) and nonalcoholic steatohepatitis (NASH), two of the most common forms of liver disease worldwide [112, 133] . Although the primary etiology of ASH and NASH is different, the pathology of ASH is remarkably similar to that of NASH, suggesting some common pathogenic mechanism. These two diseases have almost identical histology characterized by steatosis (macrovesicular > microvesicular), mixed lobular inflammation with scattered polymorphonuclear leukocytes as well as mononuclear cells and hepatocellular cell death due to sensitivity to oxidative stress [112, [133] [134] [135] [136] . The pathogenesis of ASH and NASH is currently unknown. A prevalent view according to the two hit hypothesis is that fat infiltration in hepatocytes sensitizes to secondary hits, promoting hepatocellular death, inflammation and fibrosis reflecting disease progression. However, we postulated that the type rather than the amount of fat plays a critical role in the transition from steatosis to ASH/NASH. In line with this hypothesis, previous studies have shown that chronic alcohol feeding in various models results in the depletion of mGSH due to cholesterol loading in mitochondria [6, 109, 110, 112, 137, 138] and that strategies aimed to correct the loss of mitochondrial membrane fluidity restore the mitochondrial transport of GSH and replenish the mGSH pool in alcohol-fed models. This is of relevance in TNF susceptibility as mGSH depletion primes mitochondria to TNF-mediated mitochondrial outer membrane permeabilization by Bax through cardiolipin peroxidation [76] . The mechanisms of alcohol-induced lipogenesis involved endoplasmic reticulum (ER) stress, which triggers the activation of transcription factors SREBP-1c and SREBP-2, resulting in de novo synthesis of fatty acids and cholesterol [133] . Altered alcohol-induced ER stress, in turn, involved perturbed methionine metabolism and subsequent hyperhomocysteinemia [139] . Indeed, supplementing alcohol-fed mice with betaine prevented hyperhomocysteinemia and subsequent ER stress [140] . In line with these findings, we observed that tauroursodeoxycholic acid, a chemical chaperone shown to prevent ER stress in ob/ob mice [141] , restored mGSH pool in alcohol fed rats [137] and blocked alcohol-induced ER stress Similarly, using nutritional and genetic models of hepatic steatosis, we have described that free cholesterol loading, but not free fatty acids or triglycerides, sensitizes to TNF-and Fas-induced steatohepatitis [75] . The mechanism involved cholesterol-mediated mGSH depletion as mGSH replenishment by Sadenosyl-L-methionine or GSH ethyl ester protected mice fed high cholesterol diet against LPS-induced liver injury. Although mGSH depletion has been observed in models and patients with NASH [142] , other mitochondrial antioxidant defenses are also affected, including the activity of SOD2. This outcome contributes to increased superoxide anion and subsequent peroxynitrite levels that target mitochondrial proteins. Therefore, strategies such as the use of SOD mimetics aimed to improve SOD-2 activity may be of relevance in steatohepatitis. However, the use of SOD mimetics in the face of coexisting mGSH depletion leads to increased hydrogen peroxide, contributing to hepatocellular injury and inflammation in models of nutritional steatohepatitis [143] . These findings widen the concept of oxidative stress implying the importance of a delicate equilibrium between antioxidants to prevent accumulation of reactive species. In addition, the concept that oxidative stress does not necessarily reflect the unbalance between ROS and antioxidants helps explain the failure of antioxidant treatment so far in human liver diseases. Data and models described here could offer an explanation for the important discrepancy between the overwhelming evidence for an important role of ROS and the common clinical failure of trials.
Other pathological settings
In humans, caveolin-1 (CAV1) mutations result in lipodystrophy, cell transformation, and cancer. Moreover, CAV1 gene-disrupted mice exhibit cardiovascular diseases, diabetes, cancer, atherosclerosis, and pulmonary fibrosis. The mechanisms underlying these disparate effects are unknown, but there are a variety of mild phenotypes that link the loss of CAV function with unrelated diseases [144] [145] [146] , which are likely explained by metabolic failure and oxidative stress [147] . Caveolae are distinctive invaginations of the plasma membrane with reduced fluidity, reflecting cholesterol accumulation, and are present in most mammalian cells [148, 149] . Caveolins (CAVs), integrated plasma membrane proteins, are essential components of caveolae, and complex signaling regulators with numerous partners and whose activity is highly dependent on cellular context [150, 151] . CAV-1 proteins bind cholesterol with high affinity [152] , and CAV's ability to move between these compartments might contribute to regulation of cholesterol fluxes and distributions within cells [148, 152, 153] .
In a recent study, it has been uncovered that loss of CAV1 alters mitochondrial function, which may provide a single underlying mechanism for the myriad of pathologies related to CAV1 mutations [129] . Without CAV1, free cholesterol accumulates in mitochondrial membranes, increasing membrane viscosity and reducing efficiency of the respiratory chain and depleting mGSH [121] . Indeed, this mitochondrial dysfunction predisposes CAV1-deficient animals to mitochondrial-related diseases such as steatohepatitis and neurodegeneration.
CAV1 deficiency impairs mitochondria by promoting an increased influx and accumulation of free cholesterol in mitochondrial membranes. Although in this particular study only the effect of the mitochondrial failure caused by CAV1 deficiency in liver, brain, and fibroblasts was addressed, naturally occurring CAV1 deficiencies in humans cause disease in other tissues as well [150] . In the lung, for instance, CAV1 is highly expressed and a recent study has been reported that CAV1 deletion results in major functional aberrations, suggesting that caveolin-1 may be crucial to lung homeostasis and development [154] .
Furthermore, generation of mutant mice that under-express CAV1 results in severe functional distortion with phenotypes covering the entire spectrum of known lung diseases, including pulmonary hypertension, fibrosis, increased endothelial permeability, and immune defects [155] . The contribution, however, of mitochondrial cholesterol or mGSH in the lung pathogenesis in CAV1 deficient animals remains to be elucidated.
As described above, mitochondrial oxidative stress is at the heart of many pathological settings. Since lipophilic cations accumulate in mitochondria, the covalent attachment of a neutral bioactive compound to a lipophilic cation should lead to its selective delivery to mitochondria. In this regard, alkyltriphenylphosphonium (TPP) cations are an excellent tool for the delivery of compounds to mitochondria as they preferentially accumulate (about hundredfold) within mitochondria in cells making it possible to deliver a wide range of mitochondria-targeted lipophilic TPP cations [156, 157] . Murphy and coworkers have extended this concept to develop a series of cationic antioxidants that include derivatives of the endogenous antioxidants ubiquinol (MitoQ), alphatocopherol (MitoVit E), and of the synthetic spin trap PBN (MitoPBN) [156] .
These compounds have been found to block oxidative damage in isolated mitochondria and cells far more effectively than untargeted antioxidant analogs due to their concentration within mitochondria, and its oral administration leads to their accumulation in the brain, heart, muscle and liver [143, 156] . In fact,
MitoQ has been used in a range of in vivo studies, in rats and mice, and in two phase II human trials demonstrating that it can be safely delivered to patients with promising results, lending further support that mitochondria-targeted antioxidants may be applicable to a wide range of human pathologies that involve mitochondrial oxidative damage [158] .
Final Remarks
Mitochondria play an essential role in maintaining cells alive by providing the energy needed for multiple signaling cascades and functions. The consumption of molecular oxygen in the respiratory chain is not only the driving force for the ATP synthesis required for cell viability, but also the source of ROS that target mitochondrial and extramitochondrial processes. Mitochondrial GSH plays a critical role to control the damaging effects of mitochondrial generated ROS, and hence its regulation modulates cell death susceptibility and disease progression. In particular, understanding the regulation of mGSH transport may provide novel opportunities for treatment of liver diseases and neurodegeneration. In this regard, evidence has shown that mGSH depletion contributes to susceptibility of hepatocytes or neurons to stimuli that generate oxidative stress including inflammatory cytokines, hypoxia or amyloid β-peptide.
Since a key feature of mGSH is that its import from cytosol depends on appropriate mitochondrial membrane physical properties, strategies aimed to increase mGSH by boosting cytosol GSH (e.g. NAC) may not be an optimal approach for steatohepatitis or Alzheimer disease, as it would result in mainly increasing cytosol GSH without replenishing mGSH levels. In healthy mitochondria, mGSH levels can cope with the ROS generated after an apoptotic stimulus. However, in cholesterol enriched mitochondria, the mGSH transport is concomitantly decreased resulting in mGSH depletion. mGSH levels below a certain threshold will compromise ROS detoxification leading to its accumulation resulting ultimately in cardiolipin oxidation and cell death.
